4.6 Article

Novel biomarkers of AKI: the challenges of progress 'Amid the noise and the haste'

期刊

NEPHROLOGY DIALYSIS TRANSPLANTATION
卷 28, 期 2, 页码 235-238

出版社

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfs595

关键词

-

向作者/读者索取更多资源

The clinical integration of novel biomarkers specific for kidney damage have brought the promise of a new era in our understanding of and care for those patients susceptible to or suffering from acute kidney injury (AKI) and has consistently been viewed as a top research priority. The expectations are clearly high; however, as with many promises, there are often accompanying challenges and a degree of pessimism. In this issue of Nephrology Dialysis Transplantation, Van Massenhove et al. offer their 'Devil's advocacy' view in a narrative review focused on the state of novel biomarkers for the diagnosis of AKI. While AKI biomarkers would appear to clearly have value, in particular for informing on the pathobiology of AKI, the question of how to optimally utilize them remains unresolved. Their performance is influenced by patient case-mix, comorbid illness, inciting kidney injury event, timing of measurement, the specific biomarker being investigated and the selected thresholds for diagnosis, not to mention factors related to study design, methodology and how to best translate to the bedside. The challenge as the field moves forward is to fully and appropriately utilize and interpret information from AKI biomarker studies in order to understand and evaluate how to optimally utilize these novel biomarkers (or panel of biomarkers) in the susceptible patient across a spectrum of clinical settings to improve and better inform our clinical decision-making.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Urology & Nephrology

Debate: Intermittent Hemodialysis versus Continuous Kidney Replacement Therapy in the Critically Ill Patient: The Argument for CKRT

Sean M. Bagshaw, Javier A. Neyra, Ashita J. Tolwani, Ron Wald

Summary: Continuous kidney replacement therapy (CKRT) is a dominant modality in critical care, offering precise and safe treatment for critically ill patients. It has improved the recovery and independence of kidney function compared to intermittent hemodialysis. CKRT allows flexibility in adjusting solute and fluid removal based on dynamic circumstances, and enables early physical therapy and rehabilitation for patients, addressing immobility concerns.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Review Critical Care Medicine

Safety Outcomes of Direct Discharge Home From ICUs: An Updated Systematic Review and Meta-Analysis (Direct From ICU Sent Home Study)*

Vincent I. Lau, Ryan Donnelly, Sehar Parvez, Jivanjot Gill, Sean M. Bagshaw, Ian M. Ball, John Basmaji, Deborah J. Cook, Kirsten M. Fiest, Robert A. Fowler, Jonathan F. Mailman, Claudio M. Martin, Bram Rochwerg, Damon C. Scales, Henry T. Stelfox, Alla Iansavichene, Eric J. Sy

Summary: This study evaluated the impact of direct discharge home (DDH) from ICUs compared to ward transfer on safety outcomes such as readmissions, emergency department visits, and mortality. Six studies were included, and three high-quality studies involving 49,376 patients were subject to meta-analysis. The findings suggest that DDH from ICUs may have no significant difference in safety outcomes compared to ward transfer, but the evidence is of low certainty.

CRITICAL CARE MEDICINE (2023)

Correction Critical Care Medicine

The frailty, outcomes, recovery and care steps of critically ill patients (FORECAST) study: pilot study results (vol 10, 23, 2022)

John Muscedere, Sean M. M. Bagshaw, Gordon Boyd, Stephanie Sibley, Patrick Norman, Andrew Day, Miranda Hunt, Darryl Rolfson

INTENSIVE CARE MEDICINE EXPERIMENTAL (2023)

Article Urology & Nephrology

Fluid Management for Critically Ill Patients with Acute Kidney Injury Receiving Kidney Replacement Therapy An International Survey

Lawrence Ledoux-Hutchinson, Ron Wald, Manu L. N. G. Malbrain, Francois Martin Carrier, Sean M. Bagshaw, Rinaldo Bellomo, Neill K. J. Adhikari, Martin Gallagher, Samuel A. Silver, Josee Bouchard, Michael J. J. Connor Jr, Edward G. Clark, Jean-Maxime Cote, Javier A. Neyra, Andre Denault, William Beaubien-Souligny

Summary: This international survey aimed to evaluate current practices and knowledge gaps related to fluid removal with KRT in critically ill patients. The survey revealed variations in fluid removal targets and differences between nephrologists and intensivists in fluid management methods and adjunct assessment methods. Most physicians agreed on the need for randomized controlled trials to address knowledge gaps in fluid management strategies.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2023)

Article Critical Care Medicine

IV Vitamin C in Adults With Sepsis: A Bayesian Reanalysis of a Randomized Controlled Trial*

Federico Angriman, Fiona Muttalib, Francois Lamontagne, Neill K. J. Adhikari, LOVIT Invest

Summary: The Lessening Organ Dysfunction with Vitamin C trial showed that vitamin C has a harmful effect on 28-day death or persistent organ dysfunction. A post hoc Bayesian reanalysis confirmed that there is a high probability of harm in using vitamin C for adult patients with infection and vasopressor support.

CRITICAL CARE MEDICINE (2023)

Article Critical Care Medicine

Intrapulmonary and Intracardiac Shunts in Adult COVID-19 Versus Non-COVID Acute Respiratory Distress Syndrome ICU Patients Using Echocardiography and Contrast Bubble Studies (COVID-Shunt Study): A Prospective, Observational Cohort Study

Vincent I. Lau, Graham D. Mah, Xiaoming Wang, Leon Byker, Andrea Robinson, Lazar Milovanovic, Aws Alherbish, Jeffrey Odenbach, Cristian Vadeanu, David Lu, Leo Smyth, Mitchell Rohatensky, Brian Whiteside, Phillip Gregoire, Warren Luksun, Sean van Diepen, Dustin Anderson, Sanam Verma, Jocelyn Slemko, Peter Brindley, Demetrios J. Kustogiannis, Michael Jacka, Andrew Shaw, Matt Wheatley, Jonathan Windram, Dawn Opgenorth, Nadia Baig, Oleksa G. Rewa, Sean M. Bagshaw, Brian M. Buchanan

Summary: A study on COVID-19 and non-COVID ARDS patients found a higher frequency of right-to-left shunts in COVID-19 patients, which was associated with in-hospital mortality.

CRITICAL CARE MEDICINE (2023)

Correction Critical Care Medicine

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (vol 48, pg 1736, 2023)

Sean M. Bagshaw, Ary Serpa Neto, Orla Smith, Matthew Weir, Haibo Qiu, Bin Du, Amanda Y. Wang, Martin Gallagher, Rinaldo Bellomo, Ron Wald

INTENSIVE CARE MEDICINE (2023)

Editorial Material Critical Care Medicine

Admission to intensive care unit after major surgery

Fernando G. Zampieri, Nazir I. Lone, Sean M. Bagshaw

INTENSIVE CARE MEDICINE (2023)

Review Medicine, General & Internal

Fluid Therapy for Critically Ill AdultsWith Sepsis A Review

Fernando G. Zampieri, Sean M. Bagshaw, Matthew W. Semler

Summary: Approximately 20% to 30% of ICU patients have sepsis. Intravenous fluids in the ICU are essential for the therapy of sepsis, as they can increase cardiac output and blood pressure, maintain or increase intravascular fluid volume, and deliver medications.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Urology & Nephrology

Sepsis-associated acute kidney injury: consensus report of the 28th Acute Disease Quality Initiative workgroup

Alexander Zarbock, Mitra K. Nadim, Peter Pickkers, Hernando Gomez, Samira Bell, Michael Joannidis, Kianoush Kashani, Jay L. Koyner, Neesh Pannu, Melanie Meersch, Thiago Reis, Thomas Rimmele, Sean M. Bagshaw, Rinaldo Bellomo, Vicenzo Cantaluppi, Akash Deep, Silvia De Rosa, Xose Perez-Fernandez, Faeq Husain-Syed, Sandra L. Kane-Gill, Yvelynne Kelly, Ravindra L. Mehta, Patrick T. Murray, Marlies Ostermann, John Prowle, Zaccaria Ricci, Emily J. See, Antoine Schneider, Danielle E. Soranno, Ashita Tolwani, Gianluca Villa, Claudio Ronco, Lui G. Forni

Summary: Sepsis-associated acute kidney injury (SA-AKI) is a common condition that is strongly associated with poor outcomes in critically ill patients. The exact cause of SA-AKI is still not fully understood, but dysfunction in microcirculation, cellular metabolism, and inflammatory responses are considered to be involved. Early identification of patients at risk and timely initiation of supportive measures are crucial for improving outcomes. Research on biomarkers for early diagnosis and clinical trials on potential therapeutic approaches are ongoing.

NATURE REVIEWS NEPHROLOGY (2023)

Article Critical Care Medicine

Protocol and statistical analysis plan for the mega randomised registry trial comparing conservative vs. liberal oxygenation targets in adults with nonhypoxic ischaemic acute brain injuries and conditions in the intensive care unit (Mega-ROX Brains)

Paul J. Young, Abdulrahman Al-Fares, Diptesh Aryal, Yaseen M. Arabi, Muhammad Sheharyar Ashraf, Sean M. Bagshaw, Mohd Basri Mat-Nor, Abigail Beane, Giovanni Borghi, Airton L. de Oliveira Manoel, Layoni Dullawe, Fathima Fazla, Tomoko Fujii, Rashan Haniffa, Carol L. Hodgson, Anna Hunt, Cassie Lawrence, Diane Mackle, Kishore Mangal, Alistair D. Nichol, Shaanti Olatunji, Aasiyah Rashan, Sumayyah Rashan, Bruno Tomazini, Jessica Kasza

Summary: This international randomized clinical trial compares the effect of conservative vs. liberal oxygen therapy on the 90-day in-hospital mortality of ICU patients with acute brain injuries. The trial aims to enroll between 7500 and 9500 participants and will assess outcomes such as mortality, duration of survival, mechanical ventilation, and length of stay.

CRITICAL CARE AND RESUSCITATION (2023)

Article Urology & Nephrology

Follow-up Care of Critically Ill Patients With Acute Kidney Injury: A Cohort Study

Rachel Jeong, Matthew T. James, Robert R. Quinn, Pietro Ravani, Sean M. Bagshaw, Henry T. Stelfox, Neesh Pannu, Alix Clarke, Ron Wald, Tyrone G. Harrison, Daniel J. Niven, Ngan N. Lam

Summary: This retrospective cohort study evaluated the follow-up care of critically ill patients with acute kidney injury (AKI). The results showed that many patients did not receive the recommended follow-up care, highlighting a gap in the transition of care for survivors of critical illness and AKI.

KIDNEY MEDICINE (2023)

Letter Anesthesiology

Making (numerical) sense of recent trials comparing balanced and normal saline intravenous solutions in the critically ill

Fernando G. Zampieri, Sean M. Bagshaw

BRITISH JOURNAL OF ANAESTHESIA (2023)

Review Critical Care Medicine

Precision management of acute kidney injury in the intensive care unit: current state of the art

Natalja L. Stanski, Camila E. Rodrigues, Michael Strader, Patrick T. Murray, Zoltan H. Endre, Sean M. Bagshaw

Summary: Acute kidney injury (AKI) is a complex syndrome characterized by a wide spectrum of pathobiology. Sub-phenotypes of AKI can be distinguished by shared features and can be used for prognostic enrichment and predictive enrichment. Biomarkers, both specific and non-specific, can aid in identifying pathobiological mechanisms and guide patient care in AKI.

INTENSIVE CARE MEDICINE (2023)

暂无数据